Molex, LLC, a global manufacturer of complete interconnect solutions, announced today that one of its subsidiaries has entered into a binding agreement to acquire Phillips-Medisize Corporation, a global leader in outsource design, development and manufacturing services for the medical industry that is a portfolio company of San Francisco, CA- based Golden Gate Capital, a private equity investment firm with approximately $15 billion of capital under management. The agreement is subject to customary closing conditions and is expected to close in the fall. Financial terms of the transaction were not disclosed.
Phillips-Medisize, which is headquartered in Hudson, WI, specializes in the medical device and diagnostics, drug delivery, and primary pharmaceutical packaging markets. It has a global design network that supports North America, Europe and China and employs more than 4,300 people in 17 production locations throughout the United States, Europe, Mexico and China. Phillips-Medisize Corporation will operate as an indirect subsidiary of Molex, LLC.
